Symbol="VIR"
AssetType="Common Stock"
Name="Vir Biotechnology Inc"
Description="Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California."
CIK="1706431"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1882377000"
EBITDA="-276062016"
PERatio="None"
PEGRatio="None"
BookValue="14.71"
DividendPerShare="0"
DividendYield="0"
EPS="-1.07"
RevenuePerShareTTM="3.356"
ProfitMargin="-0.322"
OperatingMarginTTM="-0.643"
ReturnOnAssetsTTM="-0.0646"
ReturnOnEquityTTM="-0.0724"
RevenueTTM="446295000"
GrossProfitTTM="1032030000"
DilutedEPSTTM="-1.07"
QuarterlyEarningsGrowthYOY="0.585"
QuarterlyRevenueGrowthYOY="-0.949"
AnalystTargetPrice="36.25"
TrailingPE="-"
ForwardPE="4.361"
PriceToSalesRatioTTM="1.409"
PriceToBookRatio="1.604"
EVToRevenue="0.52"
EVToEBITDA="0.789"
Beta="0.197"
num_52WeekHigh="31.55"
num_52WeekLow="12.56"
num_50DayMovingAverage="23.91"
num_200DayMovingAverage="24.76"
SharesOutstanding="133977000"
DividendDate="None"
ExDividendDate="None"
symbol="VIR"
open="14.12"
high="14.15"
low="13.63"
price="13.76"
volume="921391.00"
latest_trading_day="2023-07-27"
previous_close="14.05"
change="-0.29"
change_percent="-2.0641%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="70"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="1101548"
Change_recent_avg="0.01"
Delta_recent_avg="0.81"
Variance_recent_avg="0.41"
Change_ratio_recent_avg="0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="510"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_negative_thumbnail_id_2="1141"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0174.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="614"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0094.jpeg"
image_positive_thumbnail_id_2="991"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
